Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Radical resection for T1b gallbladder cancer: a decision analysis.

Abramson MA, Pandharipande P, Ruan D, Gold JS, Whang EE.

HPB (Oxford). 2009 Dec;11(8):656-63. doi: 10.1111/j.1477-2574.2009.00108.x.

2.

Autophagy: a new target for advanced papillary thyroid cancer therapy.

Lin CI, Whang EE, Abramson MA, Jiang X, Price BD, Donner DB, Moore FD Jr, Ruan DT.

Surgery. 2009 Dec;146(6):1208-14. doi: 10.1016/j.surg.2009.09.019.

PMID:
19958950
3.

The value of a wound score for diabetic foot infections in predicting treatment outcome: a prospective analysis from the SIDESTEP trial.

Lipsky BA, Polis AB, Lantz KC, Norquist JM, Abramson MA.

Wound Repair Regen. 2009 Sep-Oct;17(5):671-7. doi: 10.1111/j.1524-475X.2009.00521.x. Epub 2009 Aug 11.

PMID:
19671126
4.

Infection after elective colorectal surgery: bacteriological analysis of failures in a randomized trial of cefotetan vs. ertapenem prophylaxis.

Goldstein EJ, Citron DM, Merriam CV, Abramson MA.

Surg Infect (Larchmt). 2009 Apr;10(2):111-8. doi: 10.1089/sur.2007.096.

PMID:
19226203
5.

Galectin-3 regulates apoptosis and doxorubicin chemoresistance in papillary thyroid cancer cells.

Lin CI, Whang EE, Abramson MA, Donner DB, Bertagnolli MM, Moore FD Jr, Ruan DT.

Biochem Biophys Res Commun. 2009 Feb 6;379(2):626-31. doi: 10.1016/j.bbrc.2008.12.153. Epub 2009 Jan 3.

PMID:
19124005
6.

Surgical resection versus palliative chemoradiotherapy for the management of pancreatic cancer with local venous invasion: a decision analysis.

Abramson MA, Swanson EW, Whang EE.

J Gastrointest Surg. 2009 Jan;13(1):26-34. doi: 10.1007/s11605-008-0648-y. Epub 2008 Oct 23.

PMID:
18946644
7.

In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART).

Baquero F, Hsueh PR, Paterson DL, Rossi F, Bochicchio GV, Gallagher G, Lantz K, Villasenor JB, McCarroll K, Abramson MA, Chow JW.

Surg Infect (Larchmt). 2009 Apr;10(2):99-104. doi: 10.1089/sur.2008.0020.

PMID:
18831681
8.

Definitive risk factors for anastomotic leaks in elective open colorectal resection.

Suding P, Jensen E, Abramson MA, Itani K, Wilson SE.

Arch Surg. 2008 Sep;143(9):907-11; discussion 911-2. doi: 10.1001/archsurg.143.9.907.

PMID:
18794430
9.

Comparative costs of ertapenem and cefotetan as prophylaxis for elective colorectal surgery.

Wilson SE, Turpin RS, Kumar RN, Itani KM, Jensen EH, Pellissier JM, Abramson MA.

Surg Infect (Larchmt). 2008 Jun;9(3):349-56. doi: 10.1089/sur.2007.047.

PMID:
18570576
10.

Effect of body mass index and ertapenem versus cefotetan prophylaxis on surgical site infection in elective colorectal surgery.

Itani KM, Jensen EH, Finn TS, Tomassini JE, Abramson MA.

Surg Infect (Larchmt). 2008 Apr;9(2):131-7. doi: 10.1089/sur.2007.034.

PMID:
18426345
11.

A pharmacodynamic analysis of resistance trends in pathogens from patients with infection in intensive care units in the United States between 1993 and 2004.

Eagye KJ, Nicolau DP, Lockhart SR, Quinn JP, Doern GV, Gallagher G, Abramson MA.

Ann Clin Microbiol Antimicrob. 2007 Oct 1;6:11.

12.

Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004.

Lockhart SR, Abramson MA, Beekmann SE, Gallagher G, Riedel S, Diekema DJ, Quinn JP, Doern GV.

J Clin Microbiol. 2007 Oct;45(10):3352-9. Epub 2007 Aug 22.

13.

Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents.

Citron DM, Goldstein EJ, Merriam CV, Lipsky BA, Abramson MA.

J Clin Microbiol. 2007 Sep;45(9):2819-28. Epub 2007 Jul 3.

14.

The molecular biology of pancreatic cancer.

Abramson MA, Jazag A, van der Zee JA, Whang EE.

Gastrointest Cancer Res. 2007;1(4 Suppl 2):S7-S12.

15.

Comparative costs of ertapenem and piperacillin-tazobactam in the treatment of diabetic foot infections.

Tice AD, Turpin RS, Hoey CT, Lipsky BA, Wu J, Abramson MA.

Am J Health Syst Pharm. 2007 May 15;64(10):1080-6.

PMID:
17494908
16.

Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial.

Lipsky BA, Sheehan P, Armstrong DG, Tice AD, Polis AB, Abramson MA.

Int Wound J. 2007 Mar;4(1):30-8.

PMID:
17425547
18.

Polyethylene glycol versus sodium phosphate mechanical bowel preparation in elective colorectal surgery.

Itani KM, Wilson SE, Awad SS, Jensen EH, Finn TS, Abramson MA.

Am J Surg. 2007 Feb;193(2):190-4.

PMID:
17236845
19.

Does dermal thermometry predict clinical outcome in diabetic foot infection? Analysis of data from the SIDESTEP* trial.

Armstrong DG, Lipsky BA, Polis AB, Abramson MA.

Int Wound J. 2006 Dec;3(4):302-7.

PMID:
17199766
20.

Ertapenem versus cefotetan prophylaxis in elective colorectal surgery.

Itani KM, Wilson SE, Awad SS, Jensen EH, Finn TS, Abramson MA.

N Engl J Med. 2006 Dec 21;355(25):2640-51.

21.

Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial.

Lipsky BA, Armstrong DG, Citron DM, Tice AD, Morgenstern DE, Abramson MA.

Lancet. 2005 Nov 12;366(9498):1695-703.

PMID:
16291062
22.

Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections.

DiNubile MJ, Chow JW, Satishchandran V, Polis A, Motyl MR, Abramson MA, Teppler H.

Antimicrob Agents Chemother. 2005 Aug;49(8):3217-21.

23.
24.

Clinical information determines the impact of transesophageal echocardiography on the diagnosis of infective endocarditis by the duke criteria.

Roe MT, Abramson MA, Li J, Heinle SK, Kisslo J, Corey GR, Sexton DJ.

Am Heart J. 2000 Jun;139(6):945-51.

PMID:
10827373
25.

Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs?

Abramson MA, Sexton DJ.

Infect Control Hosp Epidemiol. 1999 Jun;20(6):408-11.

PMID:
10395142
26.

Predictors of prognosis and risk of acute renal failure in bacterial endocarditis.

Conlon PJ, Jefferies F, Krigman HR, Corey GR, Sexton DJ, Abramson MA.

Clin Nephrol. 1998 Feb;49(2):96-101.

PMID:
9524779
27.

Image of the month. Choledochal cyst.

Nikcevich DA, Abramson MA.

Gastroenterology. 1998 Feb;114(2):238, 423. No abstract available.

PMID:
9453481
28.

Photo quiz. Murine typhus (Rickettsia typhi)

Abramson MA, Sexton DJ.

Clin Infect Dis. 1995 Oct;21(4):859, 991. No abstract available.

PMID:
8645830
29.

Use of the Duke criteria for the diagnosis of infective endocarditis.

Dodds GA 3rd, Abramson MA, Corey GR, Kisslo J, Sexton DJ.

Clin Infect Dis. 1995 Aug;21(2):448-9. No abstract available.

PMID:
8562766
30.

Comparison of New and Old World leishmanins in an endemic region of Brazil.

Abramson MA, Dietze R, Frucht DM, Schwantz R, Kenney RT.

Clin Infect Dis. 1995 May;20(5):1292-7.

PMID:
7620013

Supplemental Content

Loading ...
Support Center